Ongoing Investigation into Qiagen N.V. (QGEN): Contact Levi & Korsinsky About Potential Fraud Ready to Announce with Confidence?
New York, New York--(Newsfile Corp. - April 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Qiagen N.V. ("Qiagen N.V.") (NYSE: QGEN) concerning potential violations of the federal securities laws.
During the previous earnings call on February 5, 2026, CEO Thierry Bernard was confident: "You will see QuantiFERON picking up in Q2 accelerating to achieve between 6% and 7% growth" in 2026. He noted Qiagen's projections remained "perfectly aligned with the target that we gave during our Capital Market Day in June 2024."
On April 28, 2026, Qiagen walked back on these claims and CFO Roland Sackers revealed the disappointing guidance: sales were now projected to "continue at a largely unchanged level from the second quarter of 2025," and investors would have to wait for QuantiFERON to "return to a more normalized growth rate in 2027."
If you suffered a loss on your Qiagen N.V. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212)363-7171
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/295389
Source: Levi & Korsinsky, LLP
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Levi & Korsinsky, LLP or all companies in the Banking / Financial Services industry.
MBIN Investor Notice: Levi & Korsinsky Investigates Merchants Bancorp for Securities Law Violations
2026-04-30 8:28 PM EDT
ATTENTION OPCH Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
2026-04-30 8:28 PM EDT
Levi & Korsinsky Launches Fraud Investigation on Behalf of Gildan Activewear Inc. (GIL) Shareholders
2026-04-30 8:28 PM EDT
Jul 29, 2025
Here’s what we’ve learned from over 200,000 regulatory filings—and how you can apply it: For the 200+ Canadian companies also listed in the United States, the stakes for regulatory compliance have never been higher. A single filing error can trigger significant stock price volatility and lead to major financial and reputational damage. SEDAR+ and EDGAR process thousands of filings every day. In just its first three months, SEDAR+ handled over 30,000 disclosures. EDGAR, meanwhile, processes...
Economy, Business and Finance
Legal Service
Litigation and Regulation
Banking / Financial Services